Table 3.
Differences between follow-up and baseline.
| Variable | N | Control | N | Rb | p-Value | ||||
|---|---|---|---|---|---|---|---|---|---|
| BMI (kg/m2) | 24 | −0.01 | ± | 0.60 | 24 | +0.10 | ± | 0.57 | 0.43 |
| Waist circumference (cm) | 24 | −0.18 | ± | 2.18 | 24 | +0.39 | ± | 3.12 | 0.46 |
| Fasting glucose (mmol/L) | 23 | +0.01 | ± | 0.35 | 22 | −0.09 | ± | 0.29 | 0.27 |
| Fasting insulin (pmol/L) | 19 | +3.10 | ± | 22.98 | 16 | +3.12 | ± | 26.49 | 0.99 |
| HbA1C (%) | 23 | −0.03 | ± | 0.13 | 23 | +0.03 | ± | 0.14 | 0.13 |
| Plasma TG (mmol/L) | 22 | −0.04 | ± | 0.53 | 23 | −0.17 | ± | 0.68 | 0.48 |
| ApoB-100 (g/L) | 23 | +0.01 | ± | 0.09 | 23 | −0.03 | ± | 0.12 | 0.30 |
| HDL-C (mmol/L) | 23 | −0.04 | ± | 0.10 | 23 | −0.01 | ± | 0.18 | 0.43 |
| LDL-C (mmol/L) | 22 | +0.01 | ± | 0.42 | 23 | +0.03 | ± | 0.42 | 0.89 |
| CRP (mg/L) | 20 | +0.90 | ± | 2.33 | 22 | −0.04 | ± | 1.59 | 0.14 |
| HOMA-IR | 13 | +0.11 | ± | 0.74 | 11 | −0.16 | ± | 0.53 | 0.33 |
| Matsuda index | 13 | −0.60 | ± | 2.08 | 11 | +0.14 | ± | 1.43 | 0.33 |
Data are means ± standard deviations. p-values were obtained by a general linear model, type III sum of squares. BMI, body mass index. HbA1C, glycated hemoglobin. TG, triglycerides. ApoB-100, Apolipoprotein B. HDL-C, high-density lipoprotein cholesterol. LDL-C, low-density lipoprotein cholesterol. CRP, C-reactive protein. HOMA-IR, homeostatic model assessment of insulin resistance.